State of New Jersey Common Pension Fund D Acquires 17,427 Shares of Oscar Health, Inc. (NYSE:OSCR)

State of New Jersey Common Pension Fund D grew its holdings in shares of Oscar Health, Inc. (NYSE:OSCRFree Report) by 18.9% during the third quarter, HoldingsChannel.com reports. The firm owned 109,590 shares of the company’s stock after acquiring an additional 17,427 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Oscar Health were worth $2,324,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Point72 Hong Kong Ltd acquired a new stake in Oscar Health during the second quarter worth approximately $78,000. Quest Partners LLC acquired a new position in Oscar Health in the 2nd quarter valued at $93,000. Amalgamated Bank lifted its position in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after acquiring an additional 1,458 shares during the period. Optimum Investment Advisors acquired a new stake in shares of Oscar Health during the 3rd quarter worth $142,000. Finally, Farallon Capital Management LLC bought a new position in shares of Oscar Health in the first quarter worth $164,000. 75.70% of the stock is owned by institutional investors.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares in the company, valued at approximately $1,384,906.18. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman Joshua Kushner acquired 276,040 shares of Oscar Health stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the purchase, the insider now owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 169,569 shares worth $3,007,069. Corporate insiders own 25.11% of the company’s stock.

Wall Street Analyst Weigh In

OSCR has been the topic of a number of analyst reports. Bank of America downgraded shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler reiterated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group assumed coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.93.

View Our Latest Research Report on OSCR

Oscar Health Price Performance

Shares of Oscar Health stock opened at $13.48 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm’s 50 day moving average is $18.36 and its 200 day moving average is $18.33. Oscar Health, Inc. has a 1 year low of $6.93 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCRGet Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same quarter last year, the company posted ($0.29) earnings per share. The firm’s quarterly revenue was up 68.3% on a year-over-year basis. Sell-side analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Read More

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCRFree Report).

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.